This position statement provides updated consensus recommendations for antiplatelet therapy specifically tailored to East Asian patients with coronary artery disease.
inhibitors observed in this population. This consensus update focuses on the latest progress and hotspot issues on antiplatelet therapy in the East Asian population with coronary artery disease and therapeutic recommendations based on the best available evidence.
Gong et al. (Tue,) studied this question.